Common Contracts
2 similar License Agreement contracts by Sol-Gel Technologies Ltd.
CERTAIN IDENTIFIED INFORMATION MARKED [***] HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.License Agreement • March 13th, 2024 • Sol-Gel Technologies Ltd. • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (this “Agreement”) is made and entered into as of June 5, 2023 (“Effective Date”) between Sol-Gel Technologies Ltd., with a principal place of business at 7 Golda Meir St. Ness Ziona Israel (“Sol-Gel”), and Searchlight Pharma Inc., with a principal place of business at 1600 Notre-Dame Street West, Suite 312, Montreal, Quebec, H3J 1M1, Canada (“SLP”). Sol-Gel and SLP may be referred to herein individually as a “Party” and collectively as the “Parties”.
LICENSE AGREEMENT BY AND BETWEEN SEARCHLIGHT PHARMA INC. AND SOL-GEL TECHNOLOGIES LTD.License Agreement • March 13th, 2024 • Sol-Gel Technologies Ltd. • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (this “Agreement”) is made and entered into as of June 5, 2023 (“Effective Date”) between Sol-Gel Technologies Ltd., with a principal place of business at 7 Golda Meir St. Ness Ziona Israel (“Sol-Gel”), and Searchlight Pharma Inc., with a principal place of business at 1600 Notre-Dame Street West, Suite 312, Montreal, Quebec, H3J 1M1, Canada (“SLP”). Sol-Gel and SLP may be referred to herein individually as a “Party” and collectively as the “Parties”.
